Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
10.09
+0.01 (0.10%)
At close: Aug 14, 2026, 4:00 PM EDT
10.29
+0.20 (1.98%)
After-hours: Aug 14, 2026, 7:59 PM EDT

CRBP Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, CRBP stock has a consensus rating of "Strong Buy" and an average price target of $34.53. The average 1-year stock price forecast is 242.22% higher than the current stock price, while the lowest is $17.25 (+70.96%) and the highest is $48 (+375.72%).

Price Target: $34.53 (+242.22%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$17.25$34.53$34.5$48
Change+70.96%+242.22%+241.92%+375.72%

Analyst Ratings

The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy899999
Buy211111
Hold000000
Sell000000
Strong Sell000000
Total101010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho Securities
Mizuho Securities
Buy
Maintains
$34$33
BuyMaintains$34$33+227.06%Aug 12, 2026
RBC Capital
RBC Capital
Buy
Maintains
$36
BuyMaintains$36+256.79%Aug 12, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$38
BuyMaintains$38+276.61%Aug 7, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$48
BuyReiterates$52$48+375.72%Aug 7, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$40$35
BuyReiterates$40$35+246.88%Aug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.25M
Revenue Next Year
2.40M
from 1.25M
Increased by 92.00%
EPS This Year
-5.43
from -5.90
EPS Next Year
-5.51
from -5.43
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
881.71K----1.25M
Gross Profit
-35.56M-16.14M-31.17M-32.22M-70.10M1.25M
Gross Margin
-4,033.50%----100.00%
Operating Income
-55.99M-34.84M-45.08M-48.72M-85.31M-118.45M
Net Income
-45.64M-42.35M-44.60M-40.21M-78.54M-116.27M
EPS
-----5.90-5.43
Free Cash Flow
-39.01M-18.72M-21.27M-29.80M-37.73M-121.08M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.0M
Avg1.3M
Lown/a

Revenue Growth

Revenue Growth20272028
High
1,500.0%
Avg
92.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-4.06
Avg-5.43
Low-6.81

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-